| Updates and advances in multiple sclerosis neurotherapeutics M Amin, CM Hersh Neurodegenerative disease management 13 (1), 47-70, 2023 | 111 | 2023 |
| Integration of traditional and e‐learning methods to improve learning outcomes for dental students in histopathology A Ariana, M Amin, S Pakneshan, E Dolan-Evans, AK Lam Journal of dental education 80 (9), 1140-1148, 2016 | 102 | 2016 |
| Thalamic injury and cognition in multiple sclerosis M Amin, D Ontaneda Frontiers in Neurology 11, 623914, 2021 | 57 | 2021 |
| New diagnosis of multiple sclerosis in the setting of mRNA COVID-19 vaccine exposure K Toljan, M Amin, A Kunchok, D Ontaneda Journal of Neuroimmunology 362, 577785, 2022 | 55 | 2022 |
| Modulatory role of miR-205 in A Salajegheh, H Vosgha, AM Rahman, M Amin, RA Smith, AKY Lam Endocrinology 55, 183-196, 2015 | 53 | 2015 |
| Interactive role of miR-126 on VEGF-A and progression of papillary and undifferentiated thyroid carcinoma A Salajegheh, H Vosgha, MA Rahman, M Amin, RA Smith, AKY Lam Human pathology 51, 75-85, 2016 | 42 | 2016 |
| Current perspectives of mi-RNA in oesophageal adenocarcinoma: Roles in predicting carcinogenesis, progression and values in clinical management M Amin, AK Lam Experimental and molecular pathology 98 (3), 411-418, 2015 | 38 | 2015 |
| Does targeted temperature management improve neurological outcome in extracorporeal cardiopulmonary resuscitation (ECPR)? M Huang, A Shoskes, I Migdady, M Amin, L Hasan, C Price, K Uchino, ... Journal of Intensive Care Medicine 37 (2), 157-167, 2022 | 30 | 2022 |
| Structural characterisation of high affinity Siglec-2 (CD22) ligands in complex with whole Burkitt’s lymphoma (BL) Daudi cells by NMR spectroscopy PD Madge, A Maggioni, M Pascolutti, M Amin, M Waespy, B Bellette, ... Scientific reports 6 (1), 36012, 2016 | 22 | 2016 |
| Drugs targeting CD20 in multiple sclerosis: pharmacology, efficacy, safety, and tolerability AK Carlson, M Amin, JA Cohen Drugs 84 (3), 285-304, 2024 | 15 | 2024 |
| A multicenter pilot study evaluating simplified central vein assessment for the diagnosis of multiple sclerosis L Daboul, CM O’Donnell, M Amin, P Rodrigues, J Derbyshire, C Azevedo, ... Multiple Sclerosis Journal 30 (1), 25-34, 2024 | 12 | 2024 |
| Effect of GBCA use on detection and diagnostic performance of the central vein sign: evaluation using a 3-T FLAIR* sequence in patients with suspected multiple sclerosis L Daboul, CM O'Donnell, Q Cao, M Amin, P Rodrigues, J Derbyshire, ... American Journal of Roentgenology 220 (1), 115-125, 2023 | 11 | 2023 |
| Clinical determinants of longitudinal disability in LGI-1-IgG autoimmune encephalitis A Aboseif, Y Li, M Amin, B Lapin, A Milinovich, JR Abbatemarco, ... Neurology: Neuroimmunology & Neuroinflammation 11 (1), e200178, 2024 | 10 | 2024 |
| Determination of brain death in patients undergoing short-term mechanical circulatory support devices I Migdady, A Shoskes, M Amin, SM Cho, A Rae-Grant, P George Heart, Lung and Circulation 31 (2), 239-245, 2022 | 9 | 2022 |
| Central nervous system vasculitis: primary angiitis of the central nervous system and central nervous system manifestations of systemic vasculitis M Amin, K Uchino, RA Hajj-Ali Rheumatic Disease Clinics 49 (3), 603-616, 2023 | 8 | 2023 |
| Myelin oligodendrocyte glycoprotein (MOG) antibodies in a patient with glioblastoma: red flags for false positivity M Amin, MA Mays, D Polston, EP Flanagan, R Prayson, A Kunchok Journal of neuroimmunology 361, 577743, 2021 | 8 | 2021 |
| Artificial intelligence and multiple sclerosis M Amin, E Martínez-Heras, D Ontaneda, F Prados Carrasco Current Neurology and Neuroscience Reports 24 (8), 233-243, 2024 | 7 | 2024 |
| Juxtacortical susceptibility changes in progressive multifocal leukoencephalopathy at the gray–white matter junction correlates with iron-enriched macrophages KR Mahajan, M Amin, M Poturalski, J Lee, D Herman, Y Zheng, ... Multiple Sclerosis Journal 27 (14), 2159-2169, 2021 | 7 | 2021 |
| Detection and quantification of MicroRNAs in esophageal adenocarcinoma M Amin, F Islam, V Gopalan, AK Lam Esophageal Adenocarcinoma: Methods and Protocols, 257-268, 2018 | 5 | 2018 |
| advances in multiple sclerosis neurotherapeutics., 2023, 13 M Amin, CMH Updates DOI: https://doi. org/10.2217/nmt-2021-0058, 47-70, 0 | 5 | |